MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MONG, S.
Right arrow Articles by CROOKE, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MONG, S.
Right arrow Articles by CROOKE, S. T.

Molecular Pharmacology, Vol 17, 100-104, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Interaction of Anthracyclines with Covalently Closed Circular DNA

SEYMOUR MONG , VIRGIL H. DUVERNAY 1, JAMES E. STRONG 1, and STANLEY T. CROOKE 2

1 Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030
2 Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030, and Bristol Laboratories, Syracuse, New York 13201

The effects of four anthracyclines, adriamycin, carminomycin, aclacinomycin, and marcellomycin, on covalently closed circular PM-2 DNA were studied. At a concentration of 5-10 µM each anthracycline induced conformational changes in PM-2 DNA demonstrated by production of diffuse staining patterns on agarose gels. No significant PM-2 DNA degradation was observed using alkaline sucrose gradient centrifugation, agarose gel electrophoresis analysis nor by a PM-2 DNA fluorescence assay using alkaline denaturation. At higher concentrations (200 µM) and in the presence of reducing agents and high temperature, the anthracyclines were able to degrade PM-2 DNA. Bleomycin A2 was used to test whether the conformational changes induced by anthracyclines were due to random breakage, and Bleomycin A2 was shown to degrade the anthracycline bound PM-2 DNA confirming that the anthracyclines did not degrade PM-2 DNA. Further, these results suggest that anthracyclines bind to PM-2 DNA, and induce significant conformational changes that do not affect Bleomycin A2-induced DNA degradation.

Note:
ACKNOWLEDGMENTS The authors wish to thank Ms. Julie Durantini for typing this manuscript. We also wish to thank Dr. A. W. Prestayko, Dr. C. H. Huang, and Dr. T. Sawyer for reviewing the manuscript. The support and guidance of Dr. Harris Busch are most appreciated.

Submitted on February 12, 1979
Accepted on July 25, 1979







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics